Compare IPCA Labs with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ALKEM LABORATORIES - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS ALKEM LABORATORIES IPCA LABS/
ALKEM LABORATORIES
 
P/E (TTM) x 24.8 24.1 102.9% View Chart
P/BV x 8.9 5.8 152.6% View Chart
Dividend Yield % 0.1 0.8 16.4%  

Financials

 IPCA LABS   ALKEM LABORATORIES
EQUITY SHARE DATA
    IPCA LABS
Mar-19
ALKEM LABORATORIES
Mar-20
IPCA LABS/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,0422,720 38.3%   
Low Rs5901,660 35.5%   
Sales per share (Unadj.) Rs298.6697.9 42.8%  
Earnings per share (Unadj.) Rs35.096.1 36.4%  
Cash flow per share (Unadj.) Rs49.4117.3 42.2%  
Dividends per share (Unadj.) Rs3.0025.00 12.0%  
Dividend yield (eoy) %0.41.1 32.2%  
Book value per share (Unadj.) Rs247.1515.2 48.0%  
Shares outstanding (eoy) m126.35119.57 105.7%   
Bonus / Rights / Conversions ESOS--  
Price / Sales ratio x2.73.1 87.1%   
Avg P/E ratio x23.322.8 102.3%  
P/CF ratio (eoy) x16.518.7 88.4%  
Price / Book Value ratio x3.34.3 77.7%  
Dividend payout %8.626.0 33.0%   
Avg Mkt Cap Rs m103,108261,879 39.4%   
No. of employees `00013.414.3 93.8%   
Total wages/salary Rs m7,87415,055 52.3%   
Avg. sales/employee Rs Th2,807.05,822.6 48.2%   
Avg. wages/employee Rs Th585.81,050.5 55.8%   
Avg. net profit/employee Rs Th329.0802.0 41.0%   
INCOME DATA
Net Sales Rs m37,73283,444 45.2%  
Other income Rs m5771,042 55.3%   
Total revenues Rs m38,30984,486 45.3%   
Gross profit Rs m6,90114,734 46.8%  
Depreciation Rs m1,8242,528 72.2%   
Interest Rs m189651 29.0%   
Profit before tax Rs m5,46512,598 43.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,0421,105 94.4%   
Profit after tax Rs m4,42211,493 38.5%  
Gross profit margin %18.317.7 103.6%  
Effective tax rate %19.18.8 217.5%   
Net profit margin %11.713.8 85.1%  
BALANCE SHEET DATA
Current assets Rs m23,77854,960 43.3%   
Current liabilities Rs m10,97532,433 33.8%   
Net working cap to sales %33.927.0 125.7%  
Current ratio x2.21.7 127.9%  
Inventory Days Days10480 130.4%  
Debtors Days Days6672 91.4%  
Net fixed assets Rs m20,36832,710 62.3%   
Share capital Rs m253239 105.7%   
"Free" reserves Rs m30,97161,368 50.5%   
Net worth Rs m31,22461,607 50.7%   
Long term debt Rs m1,4091,592 88.5%   
Total assets Rs m45,50799,433 45.8%  
Interest coverage x30.020.4 147.1%   
Debt to equity ratio x00 174.5%  
Sales to assets ratio x0.80.8 98.8%   
Return on assets %10.112.2 83.0%  
Return on equity %14.218.7 75.9%  
Return on capital %17.321.0 82.6%  
Exports to sales %45.919.1 240.5%   
Imports to sales %16.63.0 558.1%   
Exports (fob) Rs m17,30815,917 108.7%   
Imports (cif) Rs m6,2662,483 252.4%   
Fx inflow Rs m17,30816,061 107.8%   
Fx outflow Rs m6,2662,483 252.4%   
Net fx Rs m11,04213,578 81.3%   
CASH FLOW
From Operations Rs m4,9235,851 84.1%  
From Investments Rs m-1,563-7,414 21.1%  
From Financial Activity Rs m-1,832792 -231.5%  
Net Cashflow Rs m1,528-731 -209.0%  

Share Holding

Indian Promoters % 45.9 66.9 68.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.4 33.1 34.4%  
FIIs % 25.3 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 17.4 0.0 -  
Shareholders   36,892 68,381 54.0%  
Pledged promoter(s) holding % 2.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   PROCTER & GAMBLE HEALTH  STERLING BIOTECH  JUBILANT PHARMOVA   AUROBINDO PHARMA  PIRAMAL ENTERPRISES  

Compare IPCA LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

4 Reasons Why Sensex Surged 848 Points Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


May 17, 2021 03:35 PM

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE IPCA LABS WITH

MARKET STATS